Journals / Türkiye Çocuk Hastalıkları Dergisi / 2012 / Cilt: 6 - Sayı: 3

CURRENT APPROACH TO BRONCHOPULMONARY DYSPLASIA

Bronkopulmoner Displaziye Güncel Yaklaşım

Pages
185–192
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, mechanisms of lung injury in the preterm infants, the definition of new BPD, the difference between ‘‘old’’ and ‘’new’’ BPD, and the current approaches to prevent BPD have been reviewed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Improvements in antenatal and neonatal care have resulted in an increase in the survival of very preterm infants, whereas new form of Bronchopulmonary displasia (BPD) that has mild clinical course, radiological, and histopathological findings has occurred in these babies..
📊
Key Findings & Data:This new form of BPD is mainly related with a disruption of lung organogenesis and impaired pulmonary function.
💡
Conclusion & Impact:In this article, mechanisms of lung injury in the preterm infants, the definition of new BPD, the difference between ‘‘old’’ and ‘’new’’ BPD, and the current approaches to prevent BPD have been reviewed
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Bronkopulmoner displazi · yenidoğan · prematürite

Abstract

Improvements in antenatal and neonatal care have resulted in an increase in the survival of very preterm infants, whereas new form of Bronchopulmonary displasia (BPD) that has mild clinical course, radiological, and histopathological findings has occurred in these babies.. This new form of BPD is mainly related with a disruption of lung organogenesis and impaired pulmonary function. In premature infants born at the intersection of the canalicular and saccular phases of lung development, alveolar and capiller development are inhibited following exposure to the noxious effects of different risk factors. As a result, alveolar and capiller hypoplasia occur in these premature babies. These risk factors include surfactant deficiency, neonatal ventilation, oxygen therapy, reactive oxygen species, lung oedema, fetal and neonatal infections, disruption of vasculogenesis, and some antenatal factors that dysregulate subsequent lung development. In this article, mechanisms of lung injury in the preterm infants, the definition of new BPD, the difference between ‘‘old’’ and ‘’new’’ BPD, and the current approaches to prevent BPD have been reviewed

Özet

Yenidoğan bakım kalitesinin artması çok küçük prematüre bebeklerin yaşatılmasına olanak sağlamış olmakla birlikte bu bebeklerde “Yeni Bronkopulmoner Displazi” (BPD) olarak tanımlanan klinik, radyolojik ve histopatolojik bulguları daha hafif seyirli olan BPD nin yeni bir şekli ortaya çıkmıştır. Yeni BPD şekli, esas olarak akciğer gelişiminde duraksama ve pulmoner fonksiyonların bozulması ile ilişkilidir. Akciğer gelişiminin kanaliküler ve sakküler fazında doğan prematüre yenidoğanlarda çeşitli risk faktörlerinin etkisiyle alveol ve damar gelişimi sekteye uğramakta böylece alveolar ve kapiller hipoplazi ortaya çıkmaktadır. Surfaktan yetersizliği, yenidoğanın ventilasyonu, oksijen tedavisi, reaktif oksijen ürünleri, akciğer ödemi, fetal ve neonatal infeksiyonlar ve akciğer damar gelişiminde bozulma ile bazı antenatal etmenler akciğer hasarlanmasından sorumlu tutulmaktadır. Bu yazıda prematüre yenidoğanlardaki akciğer hasar mekanizmaları, yeni BPD tanımı, klasik BPD tablosundan farklılıkları, BPD den korunmaya yönelik güncel yaklaşımlar incelenmiştir.

🔖

Cite This Article

AKDAĞ, A., DİLMEN, U., URAŞ, N. (2022). CURRENT APPROACH TO BRONCHOPULMONARY DYSPLASIA. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 6 - Sayı: 3, 185–192. https://ajindex.com/articles/627589

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease follo- wing respirator therapy of hyaline-membrane disease. Bronchopul- monary dysplasia N Engl J Med 1967;276(7):357–68.
  2. Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neo- natol 2003;8(1):63-71.
  3. Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Ban- calari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996;128(4):470-8.
  4. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163(7):1723-9.
  5. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fa- naroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005;116(6):1353–60. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003;8(1):73–81.
  6. Haataja R, Rova M, Marttila R, Hallman M. TDT analysis of sur- factant protein B gene intron 4 deletion variants in Finnish preterm infants with bronchopulmonary dysplasia. ATS 2005 International Conference, 2005, May 20–25 Arch Dis Child Fetal Neonatal Ed 1999;81(3):162-7.
  7. Courtney SE, Durand DJ, Asselin JM, Hudak ML, Aschner JL, Shoemaker CT. High-frequency oscillatory ventilation versus con- ventional mechanical ventilation for very-low-birth-weight infants. N Engl J Med 2002;347(9):643–52.
  8. Johnson AH, Peacock JL, Greenough A, Marlow N, Limb ES, Marston L, et al. High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. N Engl J Med 2002;347(9):633–42.
  9. Marlow N, Greenough A, Peacock JL, Marston L, Limb ES, John- son AH, et al. Randomised trial of high frequency oscillatory ven- tilation or conventional ventilation in babies of gestational age 28 weeks or less: respiratory and neurological outcomes at 2 years. Arch Dis Child Fetal Neonatal Ed 2006;91(5):320–6.
  10. Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG.Volume-targeted versus pressure-limited ventilation in the neo- nate. Cochrane Database Syst Rev 2010;11:CD003666. Lassus P, Turanlahti M, Heikkila P, Andersson LC, Nupponen I, Sarnesto A, et al. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in per- sistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 2001;164(10 PT 1):1981-7.
  11. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Mont- gomery G,